Trade Q32 Bio Inc - QTTB CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0358 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023485% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001262% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.6371 |
| Open | 1.5371 |
| 1-Year Change | 68.47% |
| Day's Range | 1.4771 - 1.6071 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 31, 2025 | 1.6371 | -0.0600 | -3.54% | 1.6971 | 1.6971 | 1.5271 |
| Mar 28, 2025 | 1.6771 | -0.1700 | -9.20% | 1.8471 | 1.8471 | 1.6771 |
| Mar 27, 2025 | 1.8871 | -0.0300 | -1.56% | 1.9171 | 2.0071 | 1.8571 |
| Mar 26, 2025 | 1.9471 | -0.0800 | -3.95% | 2.0271 | 2.0271 | 1.9371 |
| Mar 25, 2025 | 2.0271 | -0.0800 | -3.80% | 2.1071 | 2.1071 | 1.9871 |
| Mar 24, 2025 | 2.1471 | 0.0600 | 2.87% | 2.0871 | 2.1471 | 2.0371 |
| Mar 21, 2025 | 2.0071 | -0.0400 | -1.95% | 2.0471 | 2.0771 | 1.9971 |
| Mar 20, 2025 | 2.0571 | -0.0400 | -1.91% | 2.0971 | 2.1171 | 2.0171 |
| Mar 19, 2025 | 2.1071 | 0.0000 | 0.00% | 2.1071 | 2.2171 | 2.0471 |
| Mar 18, 2025 | 2.1171 | -0.0300 | -1.40% | 2.1471 | 2.2571 | 2.0971 |
| Mar 17, 2025 | 2.1771 | 0.1800 | 9.01% | 1.9971 | 2.2771 | 1.9671 |
| Mar 14, 2025 | 1.9771 | 0.2000 | 11.25% | 1.7771 | 1.9871 | 1.7671 |
| Mar 13, 2025 | 1.8271 | -0.0200 | -1.08% | 1.8471 | 1.8771 | 1.7871 |
| Mar 12, 2025 | 1.8671 | -0.0300 | -1.58% | 1.8971 | 1.9771 | 1.8371 |
| Mar 11, 2025 | 1.8971 | -0.1000 | -5.01% | 1.9971 | 2.0171 | 1.8771 |
| Mar 10, 2025 | 2.0371 | -0.1400 | -6.43% | 2.1771 | 2.1871 | 1.9471 |
| Mar 7, 2025 | 2.1771 | -0.1500 | -6.45% | 2.3271 | 2.3271 | 2.0771 |
| Mar 6, 2025 | 2.3271 | 0.1400 | 6.40% | 2.1871 | 2.4071 | 2.1871 |
| Mar 5, 2025 | 2.2271 | 0.0900 | 4.21% | 2.1371 | 2.2571 | 2.0971 |
| Mar 4, 2025 | 2.1471 | 0.1000 | 4.88% | 2.0471 | 2.1571 | 1.9971 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Homology Medicines Company profile
About Homology Medicines Inc
Homology Medicines, Inc. is a clinical-stage genetic medicines company. The Company focuses on patients suffering from rare genetic diseases by curing the underlying cause of the disease. Its platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs), to deliver single administration genetic medicines in vivo either through gene therapy or nuclease-free gene editing across a range of genetic disorders. Its various set of AAVHSCs allows it to target, via a single injection, a range of disease-relevant tissues, including the liver, central nervous system (CNS), peripheral nervous system (PNS), bone marrow, muscle and eye. Its lead product candidate, HMI-102, is a gene therapy for the treatment of adults with phenylketonuria (PKU). Its other gene therapy product development candidates for the treatment of lysosomal storage diseases are HMI-203, for the treatment of mucopolysaccharidosis type II (MPS II) and HMI-202.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Homology Medicines Inc revenues increased from $1.7M to $33.2M. Net loss decreased 37% to $62.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Research and development - Balancing val decrease of 13% to $63.1M (expense), General and administrative - Balancing decrease of 1% to $19.8M (expense).
| Industry: | Bio Therapeutic Drugs |
1 Patriots Park
BEDFORD
MASSACHUSETTS 01730-2343
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com